Ravinder Wali to Cost-Benefit Analysis
This is a "connection" page, showing publications Ravinder Wali has written about Cost-Benefit Analysis.
Connection Strength
0.013
-
Drachenberg C, Hirsch HH, Papadimitriou JC, Mozafari P, Wali R, McKinney JD, Nogueira J, Cangro CB, Mendley S, Klassen DK, Ramos E. Cost efficiency in the prospective diagnosis and follow-up of polyomavirus allograft nephropathy. Transplant Proc. 2004 Dec; 36(10):3028-31.
Score: 0.013